Skip to content

MEDROEL

Active Private limited companyfounded 1997active for 29 yearsVaubanstraat 79, 8900 YpresKBO/BCE: BE 0461.330.713

Lifetime

24 annual accounts with figures on one time axis, 28 filings since 1998
peak of €467,550 in 2022
€459,590▲ 7.4%
lowest -€32,187 in 2017
€275,482▲ 9.1%
peak of €1.5m in 2025
€1.5m▲ 16.2%
€848,549▼ 8.0%
Board1 name since 1997
1 director
Documentsfilings and deeds
16-12-202546 days before the deadline
2025micro format
Dividend €63,647Equity from €1.3m to €1.5mCash from €141,116 to €73,141

Key points

from the 2025 annual accounts

Equity

€1.5m ▲ 16.2%

MEDROEL has made a profit without a break since 2018.

Filings

28 annual accounts since 1998
deadline200020102020

The last five annual accounts were filed 15 to 46 days before the end of the period.

Position in the sector

€1.5m

More equity than 95% of companies in human health. The sector median is €125,188, over 21,387 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as MEDROEL has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for MEDROEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-07-1997
  • deed of 13-10-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0461330713
Company renamed from DOKTER RAF ROELANDT to MEDROEL “tekst in artikel 3” (deed in Dutch) · General meeting of 15-06-2021 · Gazette deed
Purpose change “Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor…” (deed in Dutch) · General meeting of 27-06-2017 · Gazette deed
Capital increase of €471,600 to €490,192.01 The capital rose from €18,592.01 to €490,192.01 · Capital contribution: inschrijving op kapitaalverhoging in geld door enige vennoot · General meeting of 27-05-2014 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
MEDROEL Ypres €2.4m €459,590 64.2% -
DR. L. DELSUPEHE Roeselare €2.6m €462,546 72.3% -
CENTRE D'ALLERGO - PNEUMOLOGIE Brussels €2.4m €447,554 96.2% -
DR. DE GROOTE, Anesthesist-DR. HEYNEMAN, Pediater Deinze €2.5m €460,862 48.4% -
Dr. Vandervoort Zonhoven €2.4m €480,326 94.1% -
DOKTER M.P.P. ROSSEEL Aalst €2.1m €456,717 91.5% -
DOKTER A.-M DE COCK Willebroek €2.1m €475,077 94.1% -

These companies have the same main activity as MEDROEL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.1m and €2.6m, founded between 1997 and 2000.

Official details

Source: KBO
Status
Active since 25-08-1997Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
30 June
Peppol
Reachable since 02-12-2024
Company details

Annual accounts to 30-06-2025

≈ €690,000estimated
€2.4m▲ 6.2%
Filing
Filed on 16-12-2025, 46 days before the end of the filing period
Financials

Insights on MEDROEL

MEDROEL files the micro format. That format states no turnover. The gross margin rose from €130,648 in 2002 to €459,590 in 2025.

The balance sheet grew most from 2017 to 2019 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDROEL

What is the company number of MEDROEL?
The company number of MEDROEL is 0461.330.713. The VAT number is the same number with BE in front: BE 0461.330.713.
Where is MEDROEL based?
The registered office is at Vaubanstraat 79, 8900 Ypres.Company details
What does MEDROEL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDROEL?
MEDROEL is a private limited company (BV).
When was MEDROEL founded?
MEDROEL was founded on 25-08-1997.
Is MEDROEL still active?
Yes, MEDROEL is an active enterprise in the KBO register.
What is the turnover of MEDROEL?
The turnover in financial year 2025 is about €690,000. This figure is estimated from the gross margin of €459,590 and 31 comparable companies (NACE 86220). It probably lies between €610,000 and €960,000.Financials
Is MEDROEL profitable?
In financial year 2025, MEDROEL made a profit of €275,482.
Where can I find the annual accounts of MEDROEL?
MEDROEL filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDROEL due?
MEDROEL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.